These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
833 related items for PubMed ID: 19469431
1. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women. Hamkar R, Jalilvand S, Abdolbaghi MH, Jelyani KN, Esteghamati A, Hagh-goo A, Mohktari-Azad T, Nategh R. East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431 [Abstract] [Full Text] [Related]
2. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women]. Lafarga B, Noguera FJ, Pérez MC, Copado R, García A, Soria E. Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628 [Abstract] [Full Text] [Related]
3. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine. Hamkar R, Jalilvand S, Mokhtari-Azad T, Nouri Jelyani K, Dahi-Far H, Soleimanjahi H, Nategh R. J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863 [Abstract] [Full Text] [Related]
4. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine. Hamkar R, Jalilvand S, Abdolbaghi MH, Esteghamati AR, Hagh-Goo A, Jelyani KN, Mohktari-Azad T, Zahraei M, Nategh R. Vaccine; 2006 Apr 24; 24(17):3558-63. PubMed ID: 16510217 [Abstract] [Full Text] [Related]
5. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Seker S, Abasiyanik MF, Salih BA. Saudi Med J; 2004 May 24; 25(5):575-9. PubMed ID: 15138523 [Abstract] [Full Text] [Related]
6. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. Onyenekwe CC, Kehinde-Agbeyangi TA, Ofor US, Arinola OG. West Afr J Med; 2000 May 24; 19(1):23-6. PubMed ID: 10821082 [Abstract] [Full Text] [Related]
7. Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina. Pardon F, Vilariño M, Barbero P, Garcia G, Outon E, Gil C, Vera A, Rossi S, Distefano A. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S745-7. PubMed ID: 21954276 [Abstract] [Full Text] [Related]
8. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences. Majlessi F, Batebi A, Shariat M, Rahimi A, Azad TM. East Mediterr Health J; 2008 Sep 01; 14(3):590-4. PubMed ID: 18720623 [Abstract] [Full Text] [Related]
9. [Avidity of rubella IgG antibody in rubella virus infection]. Hoshiba T, Nishimoto H, Asamoto A, Yabuki Y. Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec 01; 45(12):1389-93. PubMed ID: 8270822 [Abstract] [Full Text] [Related]
10. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay. Hamkar R, Mahmoodi M, Nategh R, Jelyani KN, Eslami MB, Mohktari-Azad T. East Mediterr Health J; 2006 Nov 01; 12(6):775-82. PubMed ID: 17333822 [Abstract] [Full Text] [Related]
11. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
12. Fetal risk associated with rubella vaccination during pregnancy. Badilla X, Morice A, Avila-Aguero ML, Saenz E, Cerda I, Reef S, Castillo-Solórzano C. Pediatr Infect Dis J; 2007 Sep 17; 26(9):830-5. PubMed ID: 17721380 [Abstract] [Full Text] [Related]